Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Autor: Eertink, J. J., Zwezerijnen, G. J. C., Heymans, M. W., Pieplenbosch, S., Wiegers, S. E., Dührsen, U., Hüttmann, A., Kurch, L., Hanoun, C., Lugtenburg, P. J., Barrington, S. F., Mikhaeel, N. G., Ceriani, L., Zucca, E., Czibor, S., Györke, T., Chamuleau, M. E. D., Hoekstra, O. S., de Vet, H. C. W., Boellaard, R., Zijlstra, J. M.

Publikováno v: In Blood 22 June 2023 141(25):3055-3064

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Standardised lesion segmentation for imaging biomarker quantitation:a consensus recommendation from ESR and EORTC

Autor: DeSouza, N.M., Lugt, A. van der, Deroose, C.M., Alberich-Bayarri, A., Bidaut, L., Fournier, L., Costaridou, L., Oprea-Lager, D.E., Kotter, E., Smits, M., Mayerhoefer, M.E., Boellaard, R., Caroli, A., Geus-Oei, L.F. de, Kunz, W.G., Oei, E.H., Lecouvet, F., Franca, M., Loewe, C., Lopci, E., Caramella, C., Persson, A., Golay, X., Dewey, M., O'Connor, J.P.B., DeGraaf, P., Gatidis, S., Zahlmann, G., European Soc Radiology, European Org Res Treatment Canc

Publikováno v: European Society of Radiology & European Organisation for Research and Treatment of Cancer 2022, ' Standardised lesion segmentation for imaging biomarker quantitation : a consensus recommendation from ESR and EORTC ', Insights into Imaging, vol. 13, no. 1, 159, pp. 159 . https://doi.org/10.1186/s13244-022-01287-4, https://doi.org/10.1186/s13244-022-01287-4
Insights into Imaging, 13(1):159. Springer Science and Business Media Deutschland GmbH
Insights into Imaging, 13(1):159. Springer Science+Business Media
Insights into Imaging, 13(1). SPRINGER

Background Lesion/tissue segmentation on digital medical images enables biomarker extraction, image-guided therapy delivery, treatment response measurement, and training/validation for developing artificial intelligence algorithms and workflows. To e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe0e484ef30a6f5cc1f9d732d74c7ad
https://research.vumc.nl/en/publications/6655338c-7bda-46ec-8d20-51b9cd5ba705

89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Autor: Verhoeff, S.R., Donk, P.P. van de, Aarntzen, E.H.J.G., Oosting, S.F., Brouwers, A.H., Miedema, I.H.C., Voortman, J., Oordt, W.C.M.V. van, Boellaard, R., Vriens, D., Slingerland, M., Hermsen, R., Engen-van Grunsven van, Heskamp, S., Herpen, C.M.L. van

Publikováno v: Journal of Nuclear Medicine, 63(10), 1523-1530. SOC NUCLEAR MEDICINE INC
Journal of Nuclear Medicine, 63(10), 1523-1530. Society of Nuclear Medicine Inc.
The Journal of Nuclear Medicine (1978), 63, 1523-1530
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63(10), 1523-1530. SOC NUCLEAR MEDICINE INC
Verhoeff, S, van de Donk, P P, Aarntzen, E H, Oosting, S F, Brouwers, A H, Miedema, IHC, Voortman, J, Menke, C W, Boellaard, R, Vriens, D, Slingerland, M, Hermsen, R, van Engen-van Grunsven, I A C H, Heskamp, S & van Herpen, C M L 2022, ' 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer ', Journal of Nuclear Medicine, vol. 63, no. 10, pp. 1523-1530 . https://doi.org/doi:10.2967/jnumed.121.263470
The Journal of Nuclear Medicine (1978), 63, 10, pp. 1523-1530
J Nucl Med

In this PD-L1 ImagiNg to prediCt durvalumab treatment response in SCCHN (PINCH) study, we performed (89)Zr-DFO-durvalumab (anti–PD-L1 [programmed death ligand 1]) PET/CT in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1023711c6740f5640a9874962e6cb732
http://hdl.handle.net/1887/3567414